{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T07:06:35Z","timestamp":1794121595632,"version":"4.8.0"},"reference-count":32,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: The aim of this study is to evaluate the long-term efficacy and safety of the MINIject supraciliary device in patients with medically uncontrolled primary open-angle glaucoma (POAG) with up to 2 years of follow-up. Methods: A retrospective study was conducted using electronic medical records. Patients with medically uncontrolled POAG were included. Patients were either phakic, receiving combined phacoemulsification and MINIject, or pseudophakic receiving standalone MINIject. They were followed up for 24 months postoperatively. The primary outcomes were intraocular pressure (IOP) and use of IOP-lowering medications at 24 months postoperatively. Other secondary outcomes included IOP and use of glaucoma medications at 6, 12, and 18 months, success defined as 6 \u2264 IOP \u2264 18 mmHg without the use of medications (complete) or regardless of the use of medications (qualified), average change in visual field (VF) mean deviation (MD) from baseline to 24 months, and adverse events. Results: The study included 37 eyes of 37 consecutive glaucoma patients. Of these, 27 underwent combined phacoemulsification with MINIject implantation and 10 had standalone MINIject. The mean preoperative IOP was 17.95 \u00b1 4.75 mmHg on 2.16 \u00b1 1.12 glaucoma drops. At 24 months, the mean IOP was 14.58 \u00b1 4.55 on 0.69 \u00b1 0.98 medications (p = 0.002). No difference in IOP was noted between the combined and the standalone group, although the latter had a trend for more glaucoma drops. The qualified success and the complete success rates were 67.6% and 56.8%, respectively. Average VF mean deviation progression was 0.19 \u00b1 1.19 dB. No sight threatening complications occurred. Conclusions: MINIject can be a safe and effective alternative to current glaucoma devices, offering significant reduction in IOP and medication use with a good safety profile. Longer term data are needed to confirm its prolonged safety.<\/jats:p>","DOI":"10.3390\/jcm14051639","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T02:48:37Z","timestamp":1740710917000},"page":"1639","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Two-Year Data on the Efficacy and Safety of the MINIject Supraciliary Implant in Patients with Medically Uncontrolled Primary Open-Angle Glaucoma"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9303-2161","authenticated-orcid":false,"given":"Panagiotis","family":"Dervenis","sequence":"first","affiliation":[{"name":"Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-2785","authenticated-orcid":false,"given":"Nikolaos","family":"Dervenis","sequence":"additional","affiliation":[{"name":"Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool L69 7ZX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5936-1431","authenticated-orcid":false,"given":"Gerassimos","family":"Lascaratos","sequence":"additional","affiliation":[{"name":"Section of Ophthalmology, School of Life Course Sciences, King\u2019s College London, London SE1 7EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1836-772X","authenticated-orcid":false,"given":"Chrysostomos","family":"Dimitriou","sequence":"additional","affiliation":[{"name":"Colchester Eye Centre, East Suffolk and North Essex NHS Foundation Trust, Colchester CO4 5JR, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"The AGIS Investigators (2000). The Advanced Glaucoma Intervention Study (AGIS): 7. the Relationship between Control of Intraocular Pressure and Visual Field Deterioration. Am. J. Ophthalmol., 130, 429\u2013440.","DOI":"10.1016\/S0002-9394(00)00538-9"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of Intraocular Pressure and Glaucoma Progression: Results From the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of Ocular Surface Disease in Glaucoma Patients","volume":"17","author":"Leung","year":"2008","journal-title":"J. Glaucoma"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3129\/i08-076","article-title":"Multicenter Study of Compliance and Drop Administration in Glaucoma","volume":"43","author":"Kholdebarin","year":"2008","journal-title":"Can. J. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/OPTH.S407918","article-title":"Canaloplasty and Trabeculotomy with the OMNI System in Patients with Open-Angle Glaucoma: Two-Year Results from the ROMEO Study","volume":"17","author":"Williamson","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IJG.0000000000002141","article-title":"Effectiveness and Safety of iStent Infinite Trabecular Micro-Bypass for Uncontrolled Glaucoma","volume":"32","author":"Sarkisian","year":"2023","journal-title":"J. Glaucoma"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ophtha.2022.02.021","article-title":"Long-Term Outcomes from the HORIZON Randomized Trial for a Schlemm\u2019s Canal Microstent in Combination Cataract and Glaucoma Surgery","volume":"129","author":"Ahmed","year":"2022","journal-title":"Ophthalmology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ajo.2023.12.006","article-title":"Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III Trials","volume":"260","author":"Dick","year":"2024","journal-title":"Am. J. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","article-title":"Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial","volume":"130","author":"Gazzard","year":"2023","journal-title":"Ophthalmology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2147\/OPTH.S409958","article-title":"Surgical Augmentation of the Suprachoroidal Space: A Novel Material and Implant","volume":"17","author":"Ahmed","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/ICU.0b013e32834ff1e7","article-title":"Micro-Invasive Glaucoma Surgery: Current Perspectives and Future Directions","volume":"23","author":"Saheb","year":"2012","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ajo.2019.07.015","article-title":"Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study","volume":"208","author":"Reiss","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1089\/jop.2018.0036","article-title":"Supraciliary Microstent in Refractory Open-Angle Glaucoma: Two-Year Outcomes from the DUETTE Trial","volume":"34","author":"Uzunov","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12325-018-0666-4","article-title":"Prospective Evaluation of Two iStent\u00ae Trabecular Stents, One iStent Supra\u00ae Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-Year Outcomes","volume":"35","author":"Myers","year":"2018","journal-title":"Adv. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ogla.2019.06.001","article-title":"A First-in-Human Study of the Efficacy and Safety of MINIject in Patients with Medically Uncontrolled Open-Angle Glaucoma (STAR-I)","volume":"2","author":"Denis","year":"2019","journal-title":"Ophthalmol. Glaucoma"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Gl\u00e4ser, T., B\u00f6hringer, D., Evers, C., Keye, P., Reinhard, T., and L\u00fcbke, J. (2024). Clinical Results of the MINIject Implant for Suprachoroidal Drainage. J. Clin. Med., 13.","DOI":"10.3390\/jcm13102831"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/IJG.0000000000001632","article-title":"A European Study of the Performance and Safety of MINIject in Patients With Medically Uncontrolled Open-Angle Glaucoma (STAR-II)","volume":"29","author":"Denis","year":"2020","journal-title":"J. Glaucoma"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/bjophthalmol-2020-316888","article-title":"Two-Year Outcomes of the MINIject Drainage System for Uncontrolled Glaucoma from the STAR-I First-in-Human Trial","volume":"106","author":"Denis","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jcrs.2018.03.030","article-title":"Midterm Failure of Combined Phacoemulsification with Trabecular Microbypass Stenting: Clinicopathological Analysis","volume":"44","author":"Shah","year":"2018","journal-title":"J. Cataract Refract. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.ophtha.2016.06.032","article-title":"Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts","volume":"123","author":"Vold","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajo.2019.07.016","article-title":"Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent","volume":"208","author":"Lass","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/APO.0000000000000294","article-title":"Minimally Invasive Glaucoma Surgery: Where Is the Evidence?","volume":"9","author":"Gillmann","year":"2020","journal-title":"Asia-Pac. J. Ophthalmol. Phila. Pa"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00417-019-04251-z","article-title":"Two-Year Results of a Multicenter Study of the Ab Interno Gelatin Implant in Medically Uncontrolled Primary Open-Angle Glaucoma","volume":"257","author":"Reitsamer","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1111\/aos.14605","article-title":"Combined and Stand-Alone XEN 45 Gel Stent Implantation: 3-Year Outcomes and Success Predictors","volume":"99","author":"Gillmann","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/eye.2016.139","article-title":"Manchester iStent Study: 3-Year Results and Cost Analysis","volume":"30","author":"Tan","year":"2016","journal-title":"Eye"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Storp, J.J., Vietmeier, F.E., Mert\u00e9, R.-L., Koch, R., Zimmermann, J.A., Eter, N., and Br\u00fccher, V.C. (2023). Long-Term Outcomes of the PRESERFLO MicroShunt Implant in a Heterogeneous Glaucoma Cohort. J. Clin. Med., 12.","DOI":"10.3390\/jcm12134474"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/bjophthalmol-2021-320631","article-title":"One-Year Surgical Outcomes of the PreserFlo MicroShunt in Glaucoma: A Multicentre Analysis","volume":"107","author":"Tanner","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Governatori, L., Oliverio, L., Mermoud, A., Scampoli, A., Sarati, F., Carradori, A., Catalani, R., Monaco, C., Caporossi, T., and Rizzo, S. (2024). PreserFlo MicroShunt versus Trabeculectomy: An Updated Meta-Analysis and Systematic Review. Graefes Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol.","DOI":"10.1007\/s00417-024-06649-w"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ophtha.2019.10.002","article-title":"Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-Up","volume":"127","author":"Gedde","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2020.04.008","article-title":"Intraocular Pressure Following Prerandomization Glaucoma Medication Washout in the HORIZON and COMPASS Trials","volume":"216","author":"Johnson","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ophtha.2020.11.004","article-title":"Three-Year Findings of the HORIZON Trial: A Schlemm Canal Microstent for Pressure Reduction in Primary Open-Angle Glaucoma and Cataract","volume":"128","author":"Ahmed","year":"2021","journal-title":"Ophthalmology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/5\/1639\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:44:14Z","timestamp":1760028254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/5\/1639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["jcm14051639"],"URL":"https:\/\/doi.org\/10.3390\/jcm14051639","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}